Tag Archives: pharmacovigilance
GLP-1 and Reflux: The Same Signal in 3 Countries
GLP-1 receptor agonists drew a reflux signal in US, Japanese and Canadian databases, with reporting odds ratios running from 2.83 to 4.76.
Semaglutide vs Tirzepatide in FAERS: 192,791 US Reports
Semaglutide carried the cardiac reporting signals in a 2026 FAERS analysis, despite tirzepatide having more than twice as many reports overall.
Semaglutide: 6 Years of EU Reports, Two Unsettled Signals
Semaglutide drew more eye and suicidal ideation reports than dulaglutide in EudraVigilance. A 2024 cohort of 240,000 people found the opposite.